Identification of a Theileria annulata antigen expressed in multiple stages of the parasite life cycle
- PMID: 9709037
- DOI: 10.1006/expr.1998.4303
Identification of a Theileria annulata antigen expressed in multiple stages of the parasite life cycle
Abstract
In order to identify sporozoite surface molecules which may be involved in invasion and could act as potential vaccine candidates, a number of Mabs were raised in mice against T. annulata sporozoites. These were assayed for their ability to block sporozoite invasion of bovine peripheral blood mononuclear (PBM) cells in vitro. One of these, Mab 4B11, was found to neutralize sporozoite invasion to a high degree and to recognize a group of sporozoite antigens on Western blots. A T. annulata lambdagt11 genomic expression library was screened with Mab 4B11 and a positive clone containing a 900-bp insert (KP8) analysed further. Data from Southern and Northern blotting indicated that the gene containing the KP8 sequence, termed sporozoite and macroschizont gene 2 (spm2), was expressed both in T. annulata sporozoites and in later parasite life-cycle stages, macroschizont-infected leucocytes and piroplasms. The KP8 sequence was expressed in E. coli as a fusion protein with glutathione-S-transferase (GST) using the vector pGEX1lambdaT. Bovine antiserum raised against GST-KP8 recognised a single high molecular weight molecule on Western blots corresponding to one of the antigens recognised by Mab 4B11, expressed in sporozoites, macroschizont-infected leucocytes, and piroplasms. While our evidence suggests that the spm2 molecule alone is not responsible for sporozoite neutralization, it is a multistage antigen likely to function both in T. annulata sporozoites and in subsequent parasite life-cycle stages.
Copyright 1998 Academic Press.
Similar articles
-
Conservation of neutralizing determinants between the sporozoite surface antigens of Theileria annulata and Theileria parva.Exp Parasitol. 1996 Apr;82(3):229-41. doi: 10.1006/expr.1996.0030. Exp Parasitol. 1996. PMID: 8631374
-
Theileria annulata: the expression of two novel macroschizont antigens on the surface of infected mononuclear cells differs during in vitro attenuation of a virulent cell line.Exp Parasitol. 1998 Jun;89(2):228-40. doi: 10.1006/expr.1998.4292. Exp Parasitol. 1998. PMID: 9635447
-
Characterization of the gene encoding the polymorphic immunodominant molecule, a neutralizing antigen of Theileria parva.J Immunol. 1995 Aug 1;155(3):1370-81. J Immunol. 1995. PMID: 7636202
-
Current status of vaccine development against Theileria parasites.Parasitology. 2006;133 Suppl:S169-87. doi: 10.1017/S0031182006001867. Parasitology. 2006. PMID: 17274845 Review.
-
Theileria annulata: control measures, diagnosis and the potential use of subunit vaccines.Rev Sci Tech. 1990 Jun;9(2):387-403. doi: 10.20506/rst.9.2.505. Rev Sci Tech. 1990. PMID: 2132687 Review.
Cited by
-
Humoral and cellular immunity in response to an in silico-designed multi-epitope recombinant protein of Theileria annulata.Front Immunol. 2024 Aug 21;15:1400308. doi: 10.3389/fimmu.2024.1400308. eCollection 2024. Front Immunol. 2024. PMID: 39234242 Free PMC article.
-
High-resolution genotyping and mapping of recombination and gene conversion in the protozoan Theileria parva using whole genome sequencing.BMC Genomics. 2012 Sep 23;13:503. doi: 10.1186/1471-2164-13-503. BMC Genomics. 2012. PMID: 22998600 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials